Paget's disease of the breast is a rare form of
breast cancer, accounting for less than 5 percent of all breast cancers. Paget's disease of the breast starts in the breast ducts and extends to the skin of the nipple and to the dark circle of skin (
areola) around the nipple. Paget's disease of the breast isn't related to Paget's disease of the bone, a
metabolic bone disease.
Paget's disease of the breast occurs most often in women over age 50. Most women with Paget's disease of the breast have underlying infiltrating ductal breast cancer.
- Paget's disease of the nipple also occurs at other sites, most often in the groin or perianal area (extramammary Paget's disease)
- The bladder, anus, and rectum are the most common sites
- Extramammary Paget's disease is a rare intraepithelial adenocarcinoma of apocrine gland–bearing sites
Symptoms
- Flaky or scaly skin on your nipple
- Crusty, oozing or hardened skin resembling eczema, on the nipple, areola or both
- Redness
- Itching
- A burning sensation
- Straw-colored or bloody nipple discharge
- A flattened or inverted nipple
- Affected areas beyond the nipple and areola
- A distinct lump underneath the nipple and areola
- Skin and nipple changes usually in one breast only
- Fluctuating skin changes early on, making it appear as if your skin is healing on its own
Risk factors
- Older age > 50 yrs
- A personal history of breast cancer
- Family history of breast cancer
- Genetic predisposition. Defects in one of several genes, especially BRCA1 or BRCA2
- Radiation exposure
- Excess weight
- Exposure to estrogen- Taking estrogen, such as for hormone replacement therapy, also increases the risk of breast cancer for some women.
Tests and diagnosis
Clinical breast exam and physical exam
Mammography — an X-ray exam of your breast tissue
Breast biopsy
Treatment
- Simple mastectomy or lumpectomy
- Ablation of overlying cutaneous involvement, either surgically or by CO2 laser ablation
- Adjuvant therapy- anti-cancer drugs or hormone therapy to prevent a recurrence of the breast caner.